Sign In
Buy SNY
$43.98
-0.680 (-1.52%)
At Close: Jul 20, 2026
Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Ongoing discussions with the FDA regarding nrSPMS application have indicated regu
Sanofi Scores Two Major China Approvals For Rare Blood Disorder Drugs
01:11pm, Thursday, 11'th Dec 2025
The National Medical Products Administration (NMPA) in China has approved Sanofi SA's (NASDAQ: SNY) two medicines for rare hematologic diseases: Qfitlia (fitusiran) for hemophilia and Cablivi (caplaci
Sanofi's Bleeding-Disorder Treatments Get Approval in China
01:42am, Thursday, 11'th Dec 2025
Two bleeding disorder treatments for both chronic and acute conditions, Qfitlia and Cablivi, have been approved in China.
Press Release: Sanofi's Qfitlia and Cablivi approved in China, expanding care for rare diseases
01:00am, Thursday, 11'th Dec 2025
Sanofi's Qfitlia and Cablivi approved in China, expanding care for rare diseases Qfitlia, the first antithrombin-lowering therapy for hemophilia, can offer consistent protection with as few as six inj
SEATTLE & CAMBRIDGE, Mass.--(BUSINESS WIRE)--InduPro, Inc., a biotechnology company defining membrane protein spatial relationships to create novel therapeutics for the treatment of cancer and autoimm
Market Today: Fed Cut Looms, Nvidia's China Shift, Target's SoHo Push, OpenAI Taps Slack CEO
05:34pm, Tuesday, 09'th Dec 2025
Stock News Fed set for âhawkish cut': Goldman Sachs (GS) and other Wall Street desks expect the Federal Reserve to deliver a third straight 25 bps rate cut wh
Callodine Capital Management LP Purchases 109,240 Shares of Sanofi $SNY
04:52am, Sunday, 07'th Dec 2025
Callodine Capital Management LP grew its holdings in Sanofi (NASDAQ: SNY) by 26.9% during the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund owned 515
Market Today: Netflix-WBD Deal, X Fined, Meta's News Pacts
05:36pm, Friday, 05'th Dec 2025
Guru Stock PicksJana Partners has made the following transactions:Reduce in MRCY by 16.66%Add in THS by 0.13%Stock News Netflix wins WBD studio deal: Netflix (N
Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns
01:35pm, Friday, 05'th Dec 2025
Vaccine makers expressed concern on Friday's decision by a U.S. advisory panel to scrap its long-standing recommendation that all infants receive a hepatitis B vaccine at birth, a shift that public he
3 Large Drug Stocks to Watch as the Industry Shows Some Recovery
10:31am, Thursday, 04'th Dec 2025
In the Large-Cap Pharmaceuticals industry, Lilly, J&J and Sanofi are worth retaining as the industry shows some recovery.
Press Release: Sanofi completes acquisition of Vicebio
05:00am, Thursday, 04'th Dec 2025
Sanofi completes acquisition of Vicebio Paris, December 4, 2025. Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”).
LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-driven Antibody Optimisation Programmes
03:00am, Thursday, 04'th Dec 2025
LONDON--(BUSINESS WIRE)-- #AI--LabGenius Therapeutics (“LabGenius”), a drug discovery company combining machine learning (ML) and high-throughput experimentation to optimise potential therapeutic
Sanofi (SAN:CA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
07:23pm, Wednesday, 03'rd Dec 2025
Sanofi (SAN:CA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
3 Potential Mid-Cap Biotech Buyout Targets In 2026
06:22pm, Wednesday, 03'rd Dec 2025
The biotech sector began December with notable weakness, as both IBB and XBI ETFs declined over two percent during trading on Monday. The sector has bounced back since. However, small biotech stocks
Sanofi (SAN:CA) Presents at Evercore 8th Annual Healthcare Conference Transcript
07:03am, Wednesday, 03'rd Dec 2025
Sanofi (SAN:CA) Presents at Evercore 8th Annual Healthcare Conference Transcript
